SNHG7 Facilitates Glioblastoma Progression by Functioning as a Molecular Sponge for MicroRNA-449b-5p and Thereby

Yaogang Chen1, Shaoyong Yuan1, Tieying Ning1

  • 1Department of Neurosurgery, The Central Hospital of Qingdao, Shandong, China.

Abstract

Insights

Small nucleolar RNA host gene 7 (SNHG7) promotes glioblastoma growth by inhibiting miR-449b-5p, which targets MYCN. This SNHG7/miR-449b-5p/MYCN axis offers a potential therapeutic strategy for glioblastoma.

Area of Science:

  • Molecular Oncology
  • Cancer Biology
  • RNA Biology

Background:

  • Long noncoding RNAs (lncRNAs) are implicated in various cancers.
  • Small nucleolar RNA host gene 7 (SNHG7) is an oncogenic lncRNA with poorly understood roles in glioblastoma.
  • Investigating SNHG7's mechanism in glioblastoma is crucial for therapeutic development.

Purpose of the Study:

  • To elucidate the biological functions of SNHG7 in glioblastoma.
  • To identify the molecular mechanism underlying SNHG7's action in glioblastoma.
  • To explore SNHG7 as a potential therapeutic target for glioblastoma.

Main Methods:

  • Quantitative real-time PCR to assess SNHG7 and miR-449b-5p expression in glioblastoma tissues and cell lines.
  • Bioinformatics analysis and dual-luciferase reporter assays to confirm interactions between SNHG7, miR-449b-5p, and MYCN.
  • Cell viability, migration, and invasion assays to evaluate SNHG7's functional impact.

Main Results:

  • SNHG7 expression is significantly upregulated in glioblastoma tissues.
  • SNHG7 acts as a molecular sponge for miR-449b-5p, leading to its repression.
  • MiR-449b-5p directly targets MYCN, and their expression levels are inversely correlated with SNHG7 levels.
  • Knockdown of SNHG7 inhibits glioblastoma cell proliferation, migration, and invasion, effects reversed by MYCN overexpression.

Conclusions:

  • SNHG7 promotes glioblastoma progression by regulating the miR-449b-5p/MYCN axis.
  • Targeting the SNHG7/miR-449b-5p/MYCN pathway presents a promising therapeutic avenue for glioblastoma.
  • This study provides novel insights into the molecular pathogenesis of glioblastoma.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K